INVEST IN SERIES ALTOS LABS

A Mission To Prolong Human Life With “Record Startup Financing”

Altos Labs is leveraging machine learning and computation to develop epigenetic reprogramming tech, to reverse aging and prolong human life.³ Driving that mission is $3B from investors like Jeff Bezos⁴ and ARCH Venture Partners,⁵ as well as a leadership team featuring a Nobel Laureate and “storied leaders” from industry and academia.⁵ Limited to 100 spots.

This offering is for membership interest in Series 45-1, a series of StartEngine Private LLC, which will own interest in the underlying company. You are not buying the underlying company's shares directly. This offering is made available through StartEngine Primary, LLC. The securities are being offered and sold only to accredited investors through general solicitation. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.